Drupal.behaviors.print = function(context) {window.print();window.close();}>
BGI to Demo RNA-seq's Ability to Predict Patient Outcomes as Part of FDA-Led SEQC Project
November 09, 2011
BGI to Demo RNA-seq's Ability to Predict Patient Outcomes as Part of FDA-Led SEQC Project
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
New Products: Eastern Biotech's Trigene; UK NHS's Cancer Test; COSMIC
March 27, 2013 / Clinical Sequencing News
Outbreak Tracking and Monitoring Emerges as Key Application for NGS in 2012
December 19, 2012 / Clinical Sequencing News
FDA Official Discusses Issues with Regulating NGS Dx Tests
June 20, 2012 / Clinical Sequencing News
Incidental Findings from Sequencing Studies Should be Returned, Say Genetics Specialists
March 21, 2012 / Clinical Sequencing News
Q&A: Matt Posard on Illumina's Clinically Focused Business Unit
March 14, 2012 / Clinical Sequencing News